loading... download flash
spacer spacer spacer spacer spacer
 
 
Press Releases


2008 | 2007 | 2006 | 2005 | 2004 | 2003

06/24/2008 Commercial Launch of Lexiscan(TM) (Regadenoson) Injection Triggers $10 Million Milestone Payment from TPG-Axon Capital to CV Therapeutics Print this press release
06/23/2008 CV Therapeutics Announces Archives of Internal Medicine Publication of Study Showing 20 Percent of Heart Attack Patients in Premier Registry Experienced Angina at One Year Print this press release
05/28/2008 CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350 Print this press release
05/27/2008 CV Therapeutics Announces Presentations at the American Diabetes Association 68th Scientific Sessions Print this press release
04/25/2008 CV Therapeutics Reports 2008 First Quarter Financial Results Print this press release
04/24/2008 European Medicines Agency Adopts Positive Opinion for Ranolazine for Treatment of Chronic Angina Print this press release
04/15/2008 CV Therapeutics Announces $185 Million Transaction with TPG-Axon Capital for Half of Royalty for Lexiscan(TM) (regadenoson) Injection Print this press release
04/14/2008 CV Therapeutics to Announce 2008 First Quarter Financial Results on Friday, April 25, 2008 Print this press release
04/10/2008 CV Therapeutics and Astellas Announce FDA Approval for Lexiscan(TM) (regadenoson) Injection Print this press release
04/01/2008 CV Therapeutics' Anti-Ischemic Therapy Ranexa(R) Significantly Reduces Cardiac Chest Pain Symptoms and Recurrent Ischemia in MERLIN-TIMI 36 Patients With Angina Print this press release
03/31/2008 New Data Shows Ranexa(R) Increases Glucose-Stimulated Insulin Secretion Print this press release
03/31/2008 Ranolazine Shortens QT Interval and Improves Cardiac Relaxation in Study of Patients With Genetic Sodium Channel Disorder Print this press release
02/26/2008 CV Therapeutics Reports 2007 Fourth Quarter and Full Year Financial Results Print this press release
02/21/2008 CV Therapeutics Announces Presentations at the American College of Cardiology 57th Annual Scientific Session Print this press release
02/14/2008 CV Therapeutics Reports Option Grants Under Nasdaq Marketplace Rule 4350 Print this press release
02/04/2008 CV Therapeutics and Medlogics Device Corporation Sign Licensing Agreement for CVT's Innovative Stent Coating Technology Print this press release
01/31/2008 CV Therapeutics to Host Investor Science Day on Thursday, February 7, 2008 Print this press release
01/30/2008 CV Therapeutics to Announce 2007 Fourth Quarter and Year End Financial Results on Tuesday, February 26, 2008 Print this press release
Printer Friendly Page
spacer
spacer
spacer spacer
Back to Top
footer header
Home | About CVT | Media | Investors | Careers | Terms of Use | Privacy Policy | Contact Us | Site Map | webmaster@cvt.com
© 1999-2008, CV Therapeutics, Inc. All rights reserved.
 
spacer
Please Note: The websites of CV Therapeutics, Inc. are not intended to provide medical advice,
nor is any information here a substitute for professional healthcare. Consult your doctor or other
healthcare provider for information about your diagnosis, treatment, or condition.